<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02915211</url>
  </required_header>
  <id_info>
    <org_study_id>MCT-Keyo-11/12/15-01</org_study_id>
    <secondary_id>196542</secondary_id>
    <nct_id>NCT02915211</nct_id>
  </id_info>
  <brief_title>Evaluation of Keyo in Children With Epilepsy</brief_title>
  <acronym>Keyo</acronym>
  <official_title>A Feasibility Study to Evaluate the Acceptability of Keyo, a Food for Special Medical Purposes (FSMP) for Use in the Ketogenic Diet (KD) With Regard to Product Tolerance, Compliance and Acceptability</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vitaflo International, Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vitaflo International, Ltd</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the tolerance, acceptability and compliance of Keyo in 20 subjects aged 3 years
      and over, with intractable epilepsy or Glut-1 DS on a KD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Qualitative assessments from subject questionnaires that allow evaluation of the
      acceptability and ease of use of the study product.

      Collection of daily data about the gastro-intestinal tolerance of the study product.

      Collection of daily data about compliance with the study product i.e. actual versus
      prescribed intake.

      Improve quality of life by increasing range of foods available for use in a ketogenic diet.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2016</start_date>
  <completion_date type="Actual">June 2016</completion_date>
  <primary_completion_date type="Actual">June 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Palatability questionnaire</measure>
    <time_frame>Day 8</time_frame>
    <description>Qualitative assessment from subject questionnaire that allows evaluation of the palatability of the study product.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ease of use daily diary</measure>
    <time_frame>Days 1-7</time_frame>
    <description>Qualitative assessments from subject questionnaires that allow evaluation of the ease of use of the study product.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>GI tolerance daily diary</measure>
    <time_frame>Days 1-7</time_frame>
    <description>Qualitative assessments from subject questionnaires that allow evaluation of the gastro-intestinal tolerance of the study product.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Product compliance daily diary</measure>
    <time_frame>Days 1-7</time_frame>
    <description>Qualitative assessments from subject questionnaires that allow evaluation of compliance with the study product, i.e. actual versus prescribed intake.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Intractable Epilepsy</condition>
  <condition>Glucose Transporter Type 1 Deficiency Syndrome</condition>
  <condition>Ketogenic Dieting</condition>
  <arm_group>
    <arm_group_label>Consumption of Keyo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will consume their normal KD and take Keyo as advised by the lead dietitian.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Keyo</intervention_name>
    <description>Keyo is a Food for Special Medical Purposes (FSMP) and is intended for use in the KD. It has a fat to protein and carbohydrate ratio of 3 to 1. This makes it appropriate for inclusion in all versions of the KD - classical, MCT, MAD and LGI. Keyo has been designed as a nutritionally complete, ready to use, pleasant tasting and versatile medical food for use in a KD.</description>
    <arm_group_label>Consumption of Keyo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  3 years and over

          -  Confirmed diagnosis of intractable epilepsy or Glut-1 DS

          -  Children must be currently established on a KD for at least 3 months, taken orally

          -  Written, informed consent by participant/carer

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Helen McCullagh, BSc, MBChB</last_name>
    <role>Principal Investigator</role>
    <affiliation>Leeds Teaching Hospitals NHS Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Central Manchester University Hospitals NHS Foundation Trust</name>
      <address>
        <city>Manchester</city>
        <state>Greater Manchester</state>
        <zip>M13 9WL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leeds Teaching Hospitals NHS Trust</name>
      <address>
        <city>Leeds</city>
        <state>West Yorkshire</state>
        <zip>LS1 3EX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 19, 2016</study_first_submitted>
  <study_first_submitted_qc>September 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 26, 2016</study_first_posted>
  <last_update_submitted>September 23, 2016</last_update_submitted>
  <last_update_submitted_qc>September 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Epilepsy</keyword>
  <keyword>Glut</keyword>
  <keyword>Ketogenic</keyword>
  <keyword>Glucose</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
    <mesh_term>Drug Resistant Epilepsy</mesh_term>
    <mesh_term>Carbohydrate Metabolism, Inborn Errors</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

